Ligand Pharmaceuticals Incorporated (LGND) short interest & short volume · 13.3% of float short
Ligand Pharmaceuticals Incorporated official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
LGND short interest fell 6.6% to 2.5M shares in the Oct 15, 2026 report (13.3% of float, 10.5 days to cover). Daily short volume averaged 68.9% of volume over the last 20 sessions, down from 74.0% the 20 sessions before, the 61st percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 2.5M
- prior 2.7M
- % of float
- 13.3%
- float 18.9M
- Days to cover
- 10.5
- avg vol 238K
- Change vs prior report
- -6.6%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 61.5%
- 68K of 111K
- 20-day average
- 68.9%
- prior 74.0%
- Percentile vs own history
- 61st
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: +5.0%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
LGND's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · LGND overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 67,977 | 110,519 | 61.5% |
| 2026-10-30 | 115,424 | 151,468 | 76.2% |
| 2026-10-29 | 104,370 | 162,121 | 64.4% |
| 2026-10-28 | 106,741 | 140,875 | 75.8% |
| 2026-10-27 | 28,962 | 53,962 | 53.7% |
| 2026-10-26 | 64,358 | 85,350 | 75.4% |
| 2026-10-23 | 169,519 | 187,299 | 90.5% |
| 2026-10-22 | 98,959 | 166,544 | 59.4% |
| 2026-10-21 | 50,648 | 85,288 | 59.4% |
| 2026-10-20 | 42,754 | 58,122 | 73.6% |
Healthcare peers with similar quant ratings
LGND is rated 3.94 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- RLMD short interest3.97 · Buy · stock
- STE short interest3.96 · Buy · stock
- GDRX short interest3.95 · Buy · stock
- IDXX short interest3.94 · Buy · stock
- TMO short interest3.93 · Buy · stock
- BHC short interest3.92 · Buy · stock
- NVST short interest3.91 · Buy · stock
- OGN short interest3.91 · Buy · stock
LGND on Lician stock screens
LGND is rated Buy (3.94 of 5) and passes 2 of 9 preset screens on the Nov 4, 2026 quant run. Build your own screen
LGND short interest FAQ
What is LGND's short interest?
Ligand Pharmaceuticals Incorporated (LGND) had 2.5M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 13.3% of its 18.9M-share float.
How many days to cover does LGND have?
10.5 days: 2.5M shares short divided by an average daily volume of 238K for the Oct 15, 2026 period.
Is LGND short interest rising or falling?
LGND short interest fell (-6.6%) from 2.7M to 2.5M shares in the Oct 15, 2026 report.
Is LGND a short squeeze candidate?
Lician's squeeze watch scores LGND 47 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 17.7/40, days to cover 25/25, change in short interest vs prior report 0/15, price change since settlement date 4/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of LGND daily volume is sold short?
68.9% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 61st percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was LGND's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Ligand Pharmaceuticals Incorporated (LGND) was 67,977 shares, 61.5% of 110,519 total volume.
How many LGND short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Ligand Pharmaceuticals Incorporated (LGND), from Oct 20, 2026 through Nov 2, 2026.
How did LGND short volume percent change from the prior cached session?
Cached FINRA short volume for Ligand Pharmaceuticals Incorporated (LGND) moved from 76.2% on Oct 30, 2026 to 61.5% on Nov 2, 2026, down 14.7 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.